Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The main purpose of this study is to evaluate safety and efficacy of a single injection of MIJ821 in addition to standard of care (SoC) pharmacological anti-depressant treatment in participants with treatment-resistant depression (TRD)
Epistemonikos ID: 3ecc2183959fbb16dc2e9e637dfe909c59378b5d
First added on: May 13, 2024